Previous studies demonstrated that magnolol, oxymatrine, selenium, and indirubin-3-monoxime were all able to attenuate inflammatory responses by inhibiting NF-κB activation in LPS-induced mouse mastitis [57–60]. The gene discussed is NFKB1; the disease is mastitis.